bekanamycin

This page covers all bekanamycin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 3-oxoacyl-[acyl-carrier-protein] synthase 3.

Targets

3-oxoacyl-[acyl-carrier-protein] synthase 3

Phase 3 pipeline (1)

• Kanamycin B · Infectious Disease
  Bekanamycin works by disrupting the bacterial cell membrane, ultimately leading to cell death.

Patent intelligence

• bekanamycin patent landscape — aggregated cliff calendar, attackable patents, originator estates